Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial.

Scott, Ingrid U; VanVeldhuisen, Paul C; Barton, Franca; Oden, Neal L; Ip, Michael S; Blodi, Barbara A; Worrall, Martin; Fish, Gary E

Scott, Ingrid U; VanVeldhuisen, Paul C; Barton, Franca; Oden, Neal L; Ip, Michael S; Blodi, Barbara A; Worrall, Martin; Fish, Gary E.

Afiliación

Scott IU; Department of Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania.
VanVeldhuisen PC; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
Barton F; The Emmes Corporation, Rockville, Maryland.
Oden NL; The Emmes Corporation, Rockville, Maryland.
Ip MS; The Emmes Corporation, Rockville, Maryland.
Blodi BA; Doheny Eye Institute, University of California, Los Angeles.
Worrall M; University of Wisconsin Fundus Photograph Reading Center, Madison.
Fish GE; Retina Centers, PC, Tucson, Arizona.

JAMA Ophthalmol ; 137(8): 932-938, 2019 Aug 01.

Article en En | MEDLINE | ID: mdl-31169862

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: JAMA Ophthalmol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google